SA
Log In
AJANTPHARM.NS
OverviewIntelligenceChart

No data available

Earnings in 2 days · May 5, 2026
Signal
Leaning Bearish1!
Price
1→
Move→+0.92%Quiet session
Volume
1→
Volume→0.6× avgNormal activity
Technical
1→
Trend↓PullbackBelow 50D, above 200D
PRICE
Prev Close
2,804.20
Open
2,790.00
Day Range2,790.00 – 2,843.80
2,790.00
2,843.80
52W Range2,329.90 – 3,228.00
2,329.90
3,228.00
56% of range
VOLUME & SIZE
Avg Volume
103.1K
Float
124.9M
FUNDAMENTALS
P/E Ratio
34.8x
EPS (TTM)
$81.29
Div Yield
No dividend
Quick Read
Earnings in 2d · May 5
Trend
PULLBACK
Price below SMA50, above SMA200
Momentum
BULLISH
revenue +15% YoY · 69% gross margin
Valuation
EXPENSIVE
P/E 35x vs ~20x sector
Health
STRONG
CR 2.9 · FCF $8.84/sh
Bullish
Key MetricsTTM
Market Cap$353.57B
Revenue TTM$51.41B
Net Income TTM$10.15B
Free Cash Flow$1.10B
Gross Margin69.3%
Net Margin19.7%
Operating Margin39.0%
Return on Equity26.1%
Return on Assets17.9%
Debt / Equity0.06
Current Ratio2.93
EPS TTM$81.21
Alpha SignalsView Intelligence →

Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.

Health Radar
5 strong1 concern
83/100
Liquidity
2.93Strong
Leverage
0.06Strong
Coverage
101.3xStrong
ROE
26.1%Strong
ROIC
33.2%Strong
Cash
$1.8BConcern
Analyst Coverage

No analyst coverage available for this stock.

Stock Health
Composite Score
4 of 6 signals bullish
7/10
Trend
●
Trend StatePullback (dip within uptrend)
~
●
Above SMA 50$2880.69 (-1.8%)
✗
●
Above SMA 200$2690.19 (+5.2%)
✓
Technicals
●
MA AlignmentGolden Cross (50D vs 200D +7.1%)
✓
Fundamentals
●
Last EarningsBeat estimates
✓
●
LiquidityCurrent Ratio 2.93 — healthy liquidity
✓
Upcoming Events
EEarnings Report · After CloseMay 4, 2026
Tomorrow
DEx-Dividend DateJul 31, 2026
In 89 days
PDividend PaymentAug 28, 2026
In 117 days
Research
Fundamentals→Financials→Analysts→Earnings→Growth→Key Metrics→Technical Analysis→Intelligence→
Technicals
Market Position
Price Levels
52W High
$3,228+14.1%
SMA 50
$2,881+1.8%
Current
$2,830
SMA 200
$2,690-4.9%
52W Low
$2,330-17.7%
52-Week RangeMid-range
$2,33056th %ile$3,228
Earnings & Analysts

ANALYST ESTIMATES

Consensus of 12 analysts
Full estimates →
Analyst revisions:EPS↓ Revised DownRevenue↓ Revised Down

Analyst consensus estimates · Actuals replace estimates as reported

YearRevenue Est.Rev GthEPS Est.EPS GthRangeAnalysts
FY2024
$43.3B
$41.9B–$44.9B
—$67.83—
±5%
High5
FY2025
$46.1B
$42.4B–$47.0B
▲ +6.5%$75.85▲ +11.8%
±5%
High11
FY2026(current)
$53.6B
$51.6B–$54.8B
▲ +16.3%$87.82▲ +15.8%
±5%
High12
Range confidence:Tight (high)ModerateWide (low)
Earnings HistoryAJANTPHARM.NS
Last 8Q
+10.9%avg beat
Beat 6 of 8 quartersMissed 2↑ Estimates rising
+11%
Q4'23
+7%
Q1'24
+38%
Q2'24
+15%
Q3'24
-2%
Q4'24
-1%
Q3'25
+10%
Q1'26
+10%
Q1'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
Financials
Dividends0.99% yield
+55.0% avg annual growth
Annual Yield0.99%
Annual Div.$28.0000
Est. Annual / Share$28.00
FrequencyAnnual
Q4'19
Q4'20
Q4'21
Q4'22
Q3'23
Q1'24
Q4'24
Q4'25

Dividend per payment — last 8 periods

News & Activity

AJANTPHARM.NS News

20 articles · 4h ago

About

No company information available

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance